Novel mentorship program tackles disparities in clinical research

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Racial and ethnic inequities are pervasive in clinical research—from the systemic factors that deter underrepresented populations from pursuing careers in science and medicine, to the discrimination, lack of support, and other hardships faced by those who do enter the biomedical profession. 

Beyond the impacts on the scientists and physicians themselves, the lack of diversity in the workforce also has clinical implications for patients of color, as implicit biases and cultural insensitivity among physicians, mistrust among patients, and lack of inclusivity in clinical trial design have led to the underrepresentation of minority patients in clinical trials.

As a step towards increasing diversity, equity, and inclusion in the clinical workforce and clinical trials, the inaugural Bristol Myers Squibb Foundation-American Association for Cancer Research Design and Implementation of Clinical Trials Workshop was held this past November (The Cancer Letter, May 21, 2021). 

The overarching goals of the program are to establish a network of clinical trials for underrepresented minority populations and to provide mentorship to develop new leaders in clinical research. 

To access this subscriber-only content please log in or renew your subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe
Roy S. Herbst, MD, PhD
BMSF-AACR course director; Chief of medical oncology, Yale Cancer Center and Smilow Cancer Hospital; Ensign Professor of Medicine and professor of pharmacology, Yale School of Medicine
Yu Shyr, PhD
BMSF-AACR course director; Chair of Department of Biostatistics and Harold L. Moses Chair in Cancer Research, Vanderbilt University Medical Center; Director, Vanderbilt Center for Quantitative Sciences; Director, Vanderbilt Technologies for Advanced Genomics Analysis and Research Design; Professor of biostatistics, biomedical informatics, and health policy
Robert A. Winn, MD
AACR-BMS course director; Director, Virginia Commonwealth University Massey Cancer Center

YOU MAY BE INTERESTED IN

U.S. Deputy Secretary for Health and Human Services, Andrea Palm, and Sweden's Minister for Health Care, Acko Ankarberg Johansson, signing the agreement. Credit: Joel Apelthun/Government Offices of SwedenThe United States and Sweden signed an agreement to step up collaborations in science and technology by focusing on cancer research.
Roy S. Herbst, MD, PhD
BMSF-AACR course director; Chief of medical oncology, Yale Cancer Center and Smilow Cancer Hospital; Ensign Professor of Medicine and professor of pharmacology, Yale School of Medicine
Yu Shyr, PhD
BMSF-AACR course director; Chair of Department of Biostatistics and Harold L. Moses Chair in Cancer Research, Vanderbilt University Medical Center; Director, Vanderbilt Center for Quantitative Sciences; Director, Vanderbilt Technologies for Advanced Genomics Analysis and Research Design; Professor of biostatistics, biomedical informatics, and health policy
Robert A. Winn, MD
AACR-BMS course director; Director, Virginia Commonwealth University Massey Cancer Center

Login